What is Insulet Corporation's share price today?
Insulet Corporation (PODD) share price today is $147.38 as of September 5, 2026 at 1:30 AM IST. The stock touched a day high of $149.88 and a day low of $145.51.What exchange does Insulet Corporation stock trade on, and under what ticker symbol?
Insulet Corporation stock trades on NASDAQ under the ticker symbol PODD.What is Insulet Corporation's market capitalization?
Insulet Corporation's market capitalization is $10.27B as of September 5, 2026 at 1:30 AM IST.What is Insulet Corporation's price-to-earnings (P/E) ratio?
Insulet Corporation's price-to-earnings (P/E) ratio is 27.79 as of September 4, 2026.What is Insulet Corporation's price-to-book (P/B) ratio?
Insulet Corporation's price-to-book (P/B) ratio is 7.23 as of September 4, 2026.Can Indian investors buy Insulet Corporation shares?
Yes, You can buy Insulet Corporation shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in Insulet Corporation shares from India?
Indian investors can buy Insulet Corporation shares in three steps: 1. Search Insulet Corporation on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from Insulet Corporation shares for Indian investors?
Since Insulet Corporation trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in Insulet Corporation shares via Tickertape?
Indian investors can start investing in Insulet Corporation (PODD) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.0678 shares at the current price of $147.38.
$
₹
$147.382.11% (-3.19)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
1D
1W
1M
1Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
27.79
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
7.23
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$5.33
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
1.16
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
12.29%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Analyst Ratings & ForecastAnalyst Ratings & Forecast
Analyst Ratings & Forecast
Analyst Ratings & Forecast
Based on 24 analysts' reports
Buy21 analysts
Hold3 analysts
Sell0 analyst
Analysts expect a +14.16% price upside over the next year
Current Price$147.38
Target Price$171.90
Company Profile
Peers
Peers
—
—
P/E Ratio
35.18
35.18
—
—
1Y Return
16.05%
16.05%
Buy Reco %
74.07
74.07
—
—
P/E Ratio
36.89
36.89
—
—
1Y Return
5.43%
5.43%
Buy Reco %
88.00
88.00
—
—
P/E Ratio
42.35
42.35
—
—
1Y Return
15.7%
15.7%
Buy Reco %
66.66
66.66
—
—
P/E Ratio
32.89
32.89
—
—
1Y Return
20.55%
20.55%
Buy Reco %
68.75
68.75
—
—
P/E Ratio
24.71
24.71
—
—
1Y Return
1.68%
1.68%
Buy Reco %
53.12
53.12
Peers & Comparison
Peers & Comparison
HealthcareMedical Devices
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Insulet Corporation | 27.79 | 7.23 | 1.16 |
| Abbott Laboratories | 35.18 | 3.68 | 1.99 |
| Danaher Corporation | 36.89 | 2.85 | 1.39 |
Price Comparison
Price Comparison
1 Month
1 Year
5 Years
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
| Financial Year | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 441.7 | 488.5 | 543.9 | 597.5 | 569 | 649.1 | 706.3 | 783.8 | 761.7 | 801.7 |
| Gross Profit | 306.8 | 330.9 | 377.1 | 430.9 | 409 | 452.2 | 510.1 | 568.6 | 529.1 | 562.6 |
| Net Income | 51.5 | 188.6 | 77.5 | 100.7 | 35.4 | 22.5 | 87.6 | 101.6 | 91.1 | 95 |
| Net Profit Margin | 11.65% | 38.60% | 14.24% | 16.85% | 6.22% | 3.46% | 12.40% | 12.96% | 11.96% | 11.84% |